ASH is Continuing Its Advocacy to Protect Vulnerable Children
American Society of Hematology (ASH) shared a post on LinkedIn:
“The American Society of Hematology is continuing its advocacy to protect vulnerable children. After submitting comments to the CDC’s Advisory Committee on Immunization Practices (ACIP) in September, ASH has reinforced its message ahead of the December meeting:
➡ Maintain the current child and adolescent immunization schedule.
➡ Preserve Hepatitis B vaccine protocols.
Children with hematologic conditions—such as sickle cell disease, leukemia, hemophilia, and other blood disorders—are immunocompromised and face heightened risks from infections that vaccines can prevent. Vaccines are not just preventive; they are lifesaving.
Read the full comment”
Get the latest from Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH